Literature DB >> 26372178

Cold Exposure Partially Corrects Disturbances in Lipid Metabolism in a Male Mouse Model of Glucocorticoid Excess.

Johanna C van den Beukel1, Mariëtte R Boon1, Jacobie Steenbergen1, Patrick C N Rensen1, Onno C Meijer1, Axel P N Themmen1, Aldo Grefhorst1.   

Abstract

High glucocorticoid concentrations are accompanied by metabolic side effects such as high plasma triglyceride (TG) concentrations. Liver, brown adipose tissue (BAT) and white adipose tissue are important regulators of plasma TG. Exposure to 4°C reduces plasma TG concentrations, and we therefore aimed to study the interaction between glucocorticoid excess and 24 hours of exposure to 4°C on lipid metabolism. For this, mice were implanted with 50-mg corticosterone or control pellets and housed for 24 hours at 23°C or 4°C 1 week later, after which various aspects of TG metabolism in liver, BAT, and white adipose tissue were studied. Corticosterone treatment resulted in a 3.8-fold increase of plasma TG concentrations. Increased TG was normalized by cold exposure, an effect still present 24 hours after cold exposure. Corticosterone treatment increased hepatic TG content by 3.5-fold and provoked secretion of large, TG-rich very low density lipoprotein particles. Cold exposure reduced very low density lipoprotein-TG secretion by approximately 50%. Corticosterone strongly decreased BAT activity: BAT weight increased by 3.5-fold, whereas uncoupling protein 1 (Ucp1) mRNA expression and Ucp1 protein content of BAT were reduced by 75% and 60%, respectively. Cold exposure partially normalized these parameters of BAT activity. The uptake of TG by BAT was not affected by corticosterone treatment but was increased 4.5-fold upon cold exposure. In conclusion, cold exposure normalizes corticosterone-induced hypertriglyceridemia, at least partly via activating BAT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26372178     DOI: 10.1210/en.2015-1092

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

Review 1.  Brown and Beige Adipose Tissues in Health and Disease.

Authors:  Liangyou Rui
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

Review 2.  Neuroendocrine control of appetite and metabolism.

Authors:  Eun-Seon Yoo; Jieun Yu; Jong-Woo Sohn
Journal:  Exp Mol Med       Date:  2021-04-09       Impact factor: 8.718

3.  11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice.

Authors:  Craig L Doig; Rachel S Fletcher; Stuart A Morgan; Emma L McCabe; Dean P Larner; Jeremy W Tomlinson; Paul M Stewart; Andrew Philp; Gareth G Lavery
Journal:  Endocrinology       Date:  2017-06-01       Impact factor: 4.736

4.  A retrospective study of NENs and miR-224 promotes apoptosis of BON-1 cells by targeting PCSK9 inhibition.

Authors:  Jian'an Bai; He Na; Xiumei Hua; Yaling Wei; Tian Ye; Yiqiang Zhang; Guo Jian; Weiwen Zeng; Lijun Yan; Qiyun Tang
Journal:  Oncotarget       Date:  2017-01-24

5.  Metabolic Abnormalities of Chronic High-Dose Glucocorticoids Are Not Mediated by Hypothalamic AgRP in Male Mice.

Authors:  Charlotte Sefton; Alison Davies; Tiffany-Jayne Allen; Jonathan R Wray; Rosemary Shoop; Antony Adamson; Neil Humphreys; Anthony P Coll; Anne White; Erika Harno
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

6.  Sex Difference in Corticosterone-Induced Insulin Resistance in Mice.

Authors:  Kasiphak Kaikaew; Jacobie Steenbergen; Theo H van Dijk; Aldo Grefhorst; Jenny A Visser
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

Review 7.  Sex Differences in Brown Adipose Tissue Function: Sex Hormones, Glucocorticoids, and Their Crosstalk.

Authors:  Kasiphak Kaikaew; Aldo Grefhorst; Jenny A Visser
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-13       Impact factor: 5.555

8.  Chaperonin 60 sustains osteoblast autophagy and counteracts glucocorticoid aggravation of osteoporosis by chaperoning RPTOR.

Authors:  Wei-Shiung Lian; Jih-Yang Ko; Yu-Shan Chen; Huei-Ching Ke; Shin-Long Wu; Chung-Wen Kuo; Feng-Sheng Wang
Journal:  Cell Death Dis       Date:  2018-09-17       Impact factor: 8.469

9.  Obeticholic acid ameliorates obesity and hepatic steatosis by activating brown fat.

Authors:  Hanlin Zhang; Meng Dong; Xiaomeng Liu
Journal:  Exp Ther Med       Date:  2021-07-14       Impact factor: 2.447

10.  Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons.

Authors:  Erika Harno; Charlotte Sefton; Jonathan R Wray; Tiffany-Jayne Allen; Alison Davies; Anthony P Coll; Anne White
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.